PILOT AND FEASIBILITY PROGRAM

试点和可行性方案：项目总结 美国印第安人和阿拉斯加原住民糖尿病翻译研究中心(CAIANDTR)培育 在糖尿病、相关疾病和健康不平等的交叉点上进行的创新研究，重点是他们的 一生中的预防、治疗和后果。为此，它为试点和可行性提供了资金 开发新方法以改善服务不足的美国印第安人和阿拉斯加人健康的项目 原生(人工智能/人工智能)群体。这种投资为新兴的研究领域提供种子，探索新的方法，以及 寻求新的合作，这些合作可能演变为独立资助的研究或示范项目。 来自初步研究的试点数据对于从国家研究院获得大量资金也是至关重要的 卫生部(NIH)、行业合作伙伴和私人基金会。因此，CAIANDTR的试点和可行性 计划每年为每个项目分配最多20,000美元，最长2年，用于科学支持 有价值的研究，严格测试实践、治疗、教育努力和可能产生影响的政策 由于糖尿病导致的人工智能/人工智能健康差距持续、普遍减少。到目前为止，项目的重点是 与招募和留住参与者和患者有关的因素；关于创新、文化知识 提高健康素养的方法；关于家庭结构和过程对坚持 治疗建议；关于组织气氛与文化的关系进行干预 成果；以及有效传播调查结果。在续订期间，这些活动支持 全国各地的调查人员，从而加强CAIANDTR作为国家资源的作用 与创新、目标和目标相关的新研究方法、技术和途径的发展 指导糖尿病研究。

PILOT AND FEASIBILITY PROGRAM: PROJECT SUMMARY The Center for American Indian and Alaska Native Diabetes Translation Research (CAIANDTR) nurtures innovative research at the intersection of diabetes, related morbidities, and health inequities, focusing on their prevention, treatment, and consequences across the lifespan. Toward this end, it funds pilot and feasibility projects that develop novel approaches to improving the health of underserved American Indian and Alaska Native (AI/AN) populations. Such investments seed emerging research areas, explore new methodologies, and pursue new collaborations that could evolve into independently funded research or demonstration projects. Pilot data from preliminary studies are also crucial for obtaining significant funding from the National Institutes of Health (NIH), industry partners, and private foundations. Accordingly, CAIANDTR's Pilot and Feasibility Program allocates up to $20,000 per year per project for a maximum of 2 years to support scientifically meritorious studies that rigorously test practices, treatments, educational efforts, and policies that can effect sustained, widespread reductions in AI/AN health disparities due to diabetes. Projects to date have focused on factors related to recruitment and retention of participants and patients; on innovative, culturally informed methods for improving health literacy; on the influence of family structure and processes on adherence to treatment recommendations; on the relationship between organizational climate and culture to intervention outcomes; and on effective dissemination of findings. During the renewal period, these activities support investigators across the country, thereby enhancing CAIANDTR's role as a national resource that contributes to the development of new research methods, technologies, and approaches pertinent to innovative, goal- directed diabetes research.